InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Morrow Phuong Khanh. Officer active across 2 companies, notably CRISPR Therapeutics AG. In total, 3 reports have been logged. Activity tracked since 7 February 2025. The latest transaction was disclosed on 14 May 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations